Literature DB >> 7030963

Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci.

I D Becker, O M Robinson, T S Bazán, M López-Osuna, R R Kretschmer.   

Abstract

The bactericidal capacity of mononuclear and polymorphonuclear phagocytes obtained from normal newborn infants and from healthy adults was evaluated in vitro, using two group B beta-hemolytic streptococci (GBBHS) serotypes (GBBHS-Ia-SS-615/28 and GBBHS-III-SS-620/50) and uniform opsonic conditions. No intertype differences in bacteriolysis of these two serotypes were observed among leukocytes from newborns or adults. As group, only polymorphonuclear phagocytes from newborns disclosed a significantly lower mean bactericidal capacity than their adult cellular counterpart, and only with respect to GBBHS-III-SS-620/50. On the other hand, 4 or 16 polymorphonuclear samples from newborns tested revealed significantly low bactericidal capacities against both GBBHS serotypes, and an additional sample revealed a bactericidal capacity against GBBHS-III-SS-620/50 alone. Interstrain variations in the intrinsic bactericidal capacity of polymorphonuclear phagocytes from newborns against GBBHS-III may exist, as suggested by a single observation made by using four clinical isolates of GBBHS-III. Such deviant phagocytic capacities of polymorphonuclear phagocytes from newborns may constitute an additional selective risk factor in the genesis of GBBHS sepsis of the newborn.

Entities:  

Mesh:

Year:  1981        PMID: 7030963      PMCID: PMC350900          DOI: 10.1128/iai.34.2.535-539.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

2.  Prospective studies of group B streptococcal infections in infants.

Authors:  M A Pass; B M Gray; S Khare; H C Dillon
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

3.  The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers.

Authors:  E L Mills; T Thompson; B Björkstén; D Filipovich; P G Quie
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

4.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Improved tests for the evaluation of neutrophil function in human disease.

Authors:  J W Alexander; D B Windhorst; R A Good
Journal:  J Lab Clin Med       Date:  1968-07

7.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

8.  Phagocytic and bacterial properties of normal human monocytes.

Authors:  R T Steigbigel; L H Lambert; J S Remington
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  Murine resistance to type III group B streptococci.

Authors:  R Kretschmer; L C Vogel; P Kelly; D Padnos; M Goldman; W M Adueh; S P Gotoff
Journal:  Infection       Date:  1980       Impact factor: 3.553

10.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  10 in total

1.  Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae.

Authors:  C Poyart; E Pellegrini; O Gaillot; C Boumaila; M Baptista; P Trieu-Cuot
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Bactericidal kinetics of newborn polymorphonuclear leukocytes against group B streptococci type III.

Authors:  M López-Osuna; R R Kretschmer
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

4.  Group B streptococci persist inside macrophages.

Authors:  P Cornacchione; L Scaringi; K Fettucciari; E Rosati; R Sabatini; G Orefici; C von Hunolstein; A Modesti; A Modica; F Minelli; P Marconi
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

5.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools.

Authors:  B J Zeligs; C D Armstrong; J B Walser; J A Bellanti
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Diminished bactericidal capacity for group B streptococci of neutrophils from children with chronic granulomatous disease.

Authors:  J Stroobant; M C Harris; C S Cody; R A Polin; S D Douglas
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Naturally occurring disseminated group B streptococcus infections in postnatal rats.

Authors:  Katherine A Shuster; Gerald A Hish; Lindsi A Selles; Mahboob A Chowdhury; Roger C Wiggins; Robert C Dysko; Ingrid L Bergin
Journal:  Comp Med       Date:  2013-02       Impact factor: 0.982

9.  Cytokine Expression by Human Macrophage-Like Cells Derived from the Monocytic Cell Line THP-1 Differs Between Treatment With Milk from Preterm- and Term-Delivering Mothers and Pasteurized Donor Milk.

Authors:  Veronique Demers-Mathieu; Robert K Huston; David C Dallas
Journal:  Molecules       Date:  2020-05-20       Impact factor: 4.411

Review 10.  Immune vulnerability of infants to tuberculosis.

Authors:  Koen Vanden Driessche; Alexander Persson; Ben J Marais; Pamela J Fink; Kevin B Urdahl
Journal:  Clin Dev Immunol       Date:  2013-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.